EUVIMEDEUVIMED entdecken
Crossref

Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg‐Negative Stage of Chronic Hepatitis B

María Mercedes Elizalde iD, María Cecilia Monzani, Nicolás Octavio Favale, Belén Bouzas, Lilia Mammana, Rodolfo Campos, Diego Flichman

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von María Mercedes Elizalde und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de Buenos Aires, Facultad de Medicina, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), CONICET, Buenos Aires, Arge…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B e Antigens, Hepatitis B virus, Promoter Regions, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: This study was funded by Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT) [PICT 2019-01456], and Universidad de Buenos Aires: UBACyT [2002022020….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B e antigen (HBeAg) seroconversion is a crucial event in the natural history of chronic hepatitis B virus (HBV) infection, marked by a significant decrease in viral load and the emergence of mutations that suppress HBeAg expression. However, these mutations alone do not fully account for the reduction in viral load. This study investigated the biological features and pathogenic roles of mutations outside the basal core promoter (BCP) and precore regions during the HBeAg‐negative stage of chronic infection. Full‐length HBV genomes from HBeAg‐positive ( n = 180) and HBeAg‐negative ( n = 328) genotype D datasets were analyzed, revealing significantly higher genomic heterogeneity in HBeAg‐negative sequences compared with HBeAg‐positive genomes (50.4 ± 16.0 vs. 26.6 ± 10.5 nucleotide changes per genome). Twenty‐six hotspot amino acid mutations associated with the HBeAg‐negative stage were identified, with over half located in the Core region. Subsequently, full‐length HBV genomes from six HBeAg‐negative patient‐derived serum samples were obtained by PCR amplification followed by Sanger sequencing. Infectious clones generated from these genomes, each carrying between 21 and 66 amino acid substitutions, were characterized, showing that mutations in this stage differentially affected viral fitness in vitro by up‐ or downregulating HBV‐DNA levels (ranging from 0.2 to 5 times those of the wild‐type isolate), modulating capsid assembly, and altering the expression, secretion, and subcellular localization of viral proteins. In conclusion, while mutations in the BCP and precore regions are the primary drivers of HBeAg seroconversion, mutations outside these regions significantly influence HBV biology and potentially contribute to viral pathogenicity, underscoring the complex interplay between host and virus during the HBeAg‐negative stage of chronic infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis B e AntigensHepatitis B virusPromoter Regions, GeneticMutationHumansGenotypeDNA, ViralGenome, ViralViral LoadMaleFemaleAdult

Stichwörter der Autor:innen

HBeAg seroconversionantigen expression and secretionhepatitis B virusmutationsviral replication

Substanzen

Hepatitis B e AntigensDNA, Viral

Autor:innen und Institutionen

  • Universidad de Buenos Aires, Facultad de Medicina, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), CONICET, Buenos Aires, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
  • Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Biología Celular y Molecular, CONICET, Buenos Aires, Argentina.
  • Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Instituto de Química y Fisicoquímica Biológicas "Profesor Dr. Alejandro C. Paladini" (IQUIFIB), Buenos Aires, Argentina.
  • Unidad de Virología, Hospital de Infecciosas "Francisco J. Muñiz", Buenos Aires, Argentina.
  • Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Virología, Buenos Aires, Argentina.

ORCID-Profile: María Mercedes Elizalde

Förderung

  • This study was funded by Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT) [PICT 2019-01456], and Universidad de Buenos Aires: UBACyT [2002022020…

Zitieren

APA

Elizalde, M. M., Monzani, M. C., Favale, N. O., Bouzas, B., Mammana, L., Campos, R., & Flichman, D. (2025). Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg‐Negative Stage of Chronic Hepatitis B. Journal of Medical Virology. https://doi.org/10.1002/jmv.70398

Vancouver

Elizalde MM, Monzani MC, Favale NO, Bouzas B, Mammana L, Campos R, et al. Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg‐Negative Stage of Chronic Hepatitis B. Journal of Medical Virology. 2025. doi:10.1002/jmv.70398

BibTeX
@article{Elizalde2025,
  author = {Elizalde, María Mercedes and Monzani, María Cecilia and Favale, Nicolás Octavio and Bouzas, Belén and Mammana, Lilia and Campos, Rodolfo and Flichman, Diego},
  title = {Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg‐Negative Stage of Chronic Hepatitis B},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70398}
}
Kostenlos starten →